The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Hillenbrand Customers: Dying to Buy
Crass jokes and mortuary humor aside, the search for “recession proof” industries continues. The recent favorite has fallen back to the ultimate recession proof industry: death. Funeral services like casket-maker Hillenbrand (NYSE: HI) provides are products that will always be in demand.
While life expectancies have been climbing over the past few decades, they’ll never climb high enough to put off the inevitable. The death rate for the U.S. has been relatively stable over the years. We lose about 8.27 people for every thousand a year. That’s a market of 2.5 million people who needed some sort of funeral services.
As the baby boomers age, the amount of Americans over age 65 will grow larger and so will the “target demographic” for funeral services.
Companies like Matthews International (Nasdaq: MATW), which also sells funeral products like mausoleums and Service Corporation International (NYSE: SCI), which runs a large network of cemeteries and funeral homes, should both do very well.
Death, as a business, goes back millennia. And with a few exceptions, namely plague disease and war, the death rate is as steady as a clock. In times of uncertainty and troubling economic conditions, that kind of steadiness is worth investigating.
Companies mentioned in this article: HI, MATW and SCI.
- Healthcare Stocks… Are They Truly Recession-Proof?
- AmerisourceBergen Corporation: Increase the “Health” of your Portfolio
- Rising Oil Means Invest Small and Local
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed